A premium portfolio of professional serums, ampoules and peels brought to 1,150+ clinics across the Emirates — on a disciplined six-rep commercial engine.
Year 1 is a build year — a structured ramp converts demos into repeat orders. By Year 3 the model matures: deeper penetration, larger basket size, and operating leverage on a fixed sales team.
Demand clusters heavily in Dubai and Abu Dhabi, which together hold roughly three-quarters of the addressable aesthetic and dermatology base — shaping where the team is deployed first.
| Emirate | Regulator | Clinics | Physicians | Skin Specialists | Total Specialists | Distribution Priority |
|---|---|---|---|---|---|---|
| Total | — | 1,150 | 1,050 | 1,585 | 2,635 |
Gross margin holds near 76% throughout. The story is operating leverage: a fixed six-rep team carries a revenue base that more than doubles, lifting EBIT margin from 11.5% to 55%.
All figures AED
Months 1–2 are near-zero revenue — sampling, demos and KOL visits. Reorders begin in Month 3 and the team reaches full run-rate from Month 6, exiting the year at AED 112K / month.
Two reps own Dubai's premium density; single reps cover Abu Dhabi, Sharjah/Ajman and the Northern Emirates, with a dedicated rep for chain and key accounts.
| Rep / Territory | Focus Segment | Target Accts | Year 1 | Year 2 | Year 3 | 3-Yr Total |
|---|---|---|---|---|---|---|
| All Reps | — | 125 | 1,009,125 | 1,615,000 | 2,260,000 | 4,885,000 |
Microneedling ampoules and hydrodermabrasion serums drive two-thirds of revenue. Every category is consumed per-treatment, creating a predictable monthly reorder cycle.
| Product | Format | COG (AED) | Selling Price | Gross Margin |
|---|
Unit gross margins above reflect selling price vs. landed product COG. The blended ~76% P&L gross margin is lower once DDP logistics, sampling and trade terms are applied across the full basket.
The portfolio powers a full protocol of physician-administered treatments — each consuming product per session and built around prescription-grade actives.
Intradermal microinjections of vitamins, minerals, amino acids and hyaluronic acid — delivering actives locally to stimulate cell regeneration and improve hydration, elasticity and radiance.
Controlled microneedles create microchannels that trigger tissue repair — activating collagen and elastin, remodeling the dermis and boosting absorption of actives to refine texture and firmness.
Controlled chemical exfoliation — superficial to deep — that drives epidermal and dermal renewal, evens tone, softens fine lines and scars, and stimulates collagen for smoother, rejuvenated skin.
Personalized supplementation of essential nutrients — vitamins, minerals, amino acids and antioxidants — dosed at optimal concentrations for each individual.
Creams, serums and gels with targeted actives — peptides, antioxidants and moisturizing agents — that complement professional procedures and maintain skin health between sessions.
Every formula is intended for healthcare professionals and prepared and dispensed only against a valid prescription, in line with current regulations.
Each rep visits 20–25 clinics weekly and can keep 20–25 accounts active on a monthly cycle. The current team covers ~500 clinics/year; scaling to 8–10 reps would reach 800–900 and nearly double the active base.